Testimonials

Collated independently by Legal 500 research team.

  • ‘A small but highly relevant and extremely professional private equity/M&A team. Excellent availability and high-quality deliverables.’
  • ‘The team is very attentive to customer needs and knows how to adapt to them. A responsive, available, and highly professional team. Excellent interpersonal skills.’
  • ‘A team with extensive knowledge of the pharmaceutical sector, a pragmatic approach and excellent interpersonal skills.'
  • 'Audrey Bontemps offers sound advice and is calm and persuasive in negotiations.'
  • ‘The team proved to be particularly innovative in terms of structuring and was able to provide us with the appropriate advice according to our requests and beyond.’
  • ‘Audrey Bontemps is a lawyer who understands her client's perspective, listens attentively to their requests, and anticipates potential risks.'

Key clients

  • Altarea
  • Amolyt Pharma
  • BRED
  • Calgon Carbon Corporation (Kuraray group)
  • FN Browning Group
  • Framatome
  • GE Vernova
  • M Partners
  • For Talents
  • Neuflize (ABN Amro)
  • Orano
  • OVHCloud

Work highlights

Advised Orano on setting up two industrial joint ventures with XTC New Energy, a leading player in Asia.
Advising FN Browning Group on the contemplated acquisition of Sofisport, a French company specializing in the manufacture and sale of ammunition for hunting rifles, together with its subsidiaries in France, Italy, Spain, the UK and Canada.
Advising Waga Energy and its founders on the buyout transaction organized by funds managed by EQT, and the founders’ reinvestment therein.
Practice head

Sophie Hagège

Other key lawyers

Alexandre de Verdun; Audrey Bontemps;